Product Name:Ranibizumab
CAS No.: 347396-82-1
Formula: C2158H3282N562O681S12
Molecular Weight:48 kDa
Type: Fab fragment
Target:VEGF-A
Antibody Form: Purified immunoglobulin
Physical Form: Solution
Storage:
Biological Activity
Ranibizumab (Anti-VEGFA) is a recombinant humanized IgG1 monoclonal antibody fragment that inhibits (VEGF-A) and degrades angiogenesis throughout the body and in the eye also interrupts the interaction of VEGF with its receptors, and thus prevents the subsequent growth of new blood vessels.
For research use only.Not for use in humans